Panacea Pharmaceuticals, Inc. Appoints Lawrence Glass as Senior Vice-President for Corporate Development.Business Editors/Health & Medical Writers BIOWIRE2K ROCKVILLE, Md.--(BW HealthWire)--May 10, 2001 Panacea Pharmaceuticals, Inc. is pleased to announce the appointment of Lawrence Glass as Senior Vice-President for Corporate Development. Mr. Glass is a manager, strategist, and scientist with more than twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights. 2. of experience in the life sciences industry. The primary emphasis of his career has been on business and corporate development, building and directing biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. , and drug development programs. Mr. Glass has particular expertise in developing interdisciplinary programs that integrate laboratory and clinical R&D with corporate development strategies. "It is a pleasure to welcome Larry as a key member of Panacea's management team," stated Hossein A. Ghanbari, Ph.D., President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Panacea. "Larry brings a wealth of expertise in the life sciences in areas such as financing, mergers and acquisitions, technology assessment, and strategic planning for the development of novel technologies and therapies." Mr. Glass most recently served as Executive Vice-President for Corporate Development & Scientific Affairs for Virco Lab, Inc., the U.S. subsidiary of Virco Group (Belgium). Prior to that, he spent nearly 20 years at SRA SrA abbr. senior airman Life Sciences, Inc., which was acquired by Virco in late 2000. At SRA, Mr. Glass served as Senior Vice-President and Director of Corporate Development and most recently as President and CEO. He was the principal architect of SRA's biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. business and built an internationally recognized team conducting pharmacogenomic and drug resistance testing, working with many of the top pharmaceutical and biotechnology companies in the world. Prior to SRA, Mr. Glass held positions at various institutions including the National Institute for Advanced Studies, the University of Minnesota (body, education) University of Minnesota - The home of Gopher. http://umn.edu/. Address: Minneapolis, Minnesota, USA. College of Medicine, and the Minneapolis Children's Hospital and Health Center. Mr. Glass stated, "Panacea's R&D programs, particularly its robust platform technology for the treatment and diagnosis of multiple cancers, present extraordinary scientific and financial opportunities for the company's investors, staff, and potential partners." About Panacea Pharmaceuticals Panacea Pharmaceuticals, Inc. is a development stage biopharmaceutical company focused on utilizing functional genomics and proteomics to develop therapeutics and diagnostics for cancer, Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , and Parkinson's disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. . More information is available at www.PanaceaPharma.com, a web site developed by Ei Web Promotion, a division of eiCommunications.com, Inc. (www.eiCommunications.com), which offers integrated communications and web development solutions for the Information Age. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion